Andy Murdock is a board director of Lloydspharmacy. He is also a board director of the Company Chemists Association, a member of the Pharmaceutical Services Negotiating Committee and a member of the Community Pharmacy Wales Committee. Andy Murdock was co-opted to the NPA Board of Management in April 2010 to represent Lloydspharmacy.
He was appointed to the Department of Health task group Medicine Concordance 2003, Choosing Health 2004 and the NHS Review Advisory Board 2007 and the Government’s ‘primary care planning group’ for pandemic flu.
In June 2009 he was appointed to the Department of Health’s Information Standard: Engagement and Development Board and in August 2009 appointed to the Competition and Co-operation Panel Clinical Reference Group.
Region: Co-opted Lloydspharmacy
Email: boardmember@npa.co.uk
